*The search scope is limited to the products and news section of this site
*The search scope is limited to the products and news section of this site
On Nov. 11, the Comprehensive Team for Joint Prevention and Control Mechanism of the State Council issued the "Notice on Further Optimizing the Prevention and Control Measures of COVID-19 in A Scientific and Precise Manner". "Measure 13" of the Notice clearly states to "Accelerate the stockpiling of...
Henan Genuine Biotech Co., Ltd. (hereinafter referred to as "Genuine Biotech") announced that the IND clinical trial application for CL-197, a next-generation oral long-acting HIV drug candidate developed by Genuine Biotech, was formally approved by the Center for Drug Evaluation (CDE) of the Nation...
On Aug. 19, 5000 bottles of Azvudine tablets donated by Genuine Biotech and Fosun Pharma arrived in Lhasa. This batch of drugs was received by the Health Commission of Tibet Autonomous Region and distributed to designated hospitals on the same day to meet the needs of first-line pandemic prevention ...
On Aug. 12, CCTV News reported that, as announced by the National Healthcare Security Administration, all drugs included in the Diagnosis and Treatment Guideline for COVID-19 can be temporarily included in the scope of medical insurance payment in accordance with the relevant regulations of the basi...
On Aug. 9, 2022, National Health Commission and National Administration of Traditional Chinese Medicine announced that Azvudine has been included in the Diagnosis and Treatment Guideline for COVID-19.Notice on the Inclusion of Azvudine in the Diagnosis and Treatment Guideline for COVID-19.To all pro...
On the morning of Aug. 2, Henan Genuine Biotech Co., Ltd. (hereinafter referred to as "Genuine Biotech") held a "Production Ceremony for Oral Drug Azvudine Tablets for COVID-19" in Pingdingshan. The event was hosted by Gao Jianli, the Executive Vice Mayor of Pingdingshan. Zhang Leiming, the Secretar...
On Jul. 26, 2022, Henan Genuine Biotech Co., Ltd. (hereinafter referred to as "Genuine Biotech") announced a strategic partnership with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as "Fosun Pharma", stock code: 600196.SH; 02196.HK). The two companies will jointly develop...
On Jul. 25, Henan Genuine Biotech Co., Ltd. (hereinafter referred to as "Genuine Biotech") announced that the registration application of small-molecule oral drug Azvudine tablets, independently developed by the company for the treatment of COVID-19, has been granted conditional approval by the Nati...
Henan Genuine Biotech Co., Ltd. (hereinafter referred to as "Genuine Biotech") announced that the results of phase III clinical trial for registration of Azvudine tablets for the treatment of COVID-19 have met the expectations. Recently, a marketing application has been formally submitted to the Nat...
The "2021 Annual Selection of Pharmaceutical Innovation and Salvation Awards" held by Securities Times was officially announced on Apr. 20, and Henan Genuine Biotech Co., Ltd. (hereinafter referred to as "Genuine Biotech") received two awards. Azvudine was awarded the "Pharmaceutical Innovation Achi...
Copyright © 2022 河南真实生物科技有限公司 All Rights Reserved 京ICP备2021026784号-1
